# Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma

> **NCT00025610** · PHASE2 · COMPLETED · sponsor: **European Infant Neuroblastoma Study Group - 1999**

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00025610
- **Lead sponsor:** European Infant Neuroblastoma Study Group - 1999
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** 2009-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025610, "Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00025610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*